Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Chondrosarcoma × HhAntag691 × Clear all

Phase

Status

Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pancreatic Neoplasms 1 Neuroectodermal Tumors, Primitive 1 Multiple Myeloma 1 Medulloblastoma 1 Lymphoma 1 Infratentorial Neoplasms 1 Chondrosarcoma, Mesenchymal 1 Chondrosarcoma, Clear Cell 1 Chondrosarcoma 1 Brain Neoplasms 1

Interventions

regorafenib 1 ivosidenib 1 durvalumab 1 Zoledronic Acid 1 Proton Therapy 1 Pharmacogenomic Testing 1 HhAntag691 1 Gemcitabine 1 Cisplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01267955 2026-03-18

Vismodegib in Treating Patients With Advanced Chondrosarcomas

National Cancer Institute (NCI)

Phase 2 Active not recruiting

45 enrolled 10 charts

Chondrosarcoma, Clear Cell, Chondrosarcoma, Chondrosarcoma, Mesenchymal

Data powered by HemOnc (CC BY 4.0) Colophon ⚡